Targeted therapies for renal cell carcinoma
Posadas, Edwin M., Limvorasak, Suwicha, Figlin, Robert A.
Published in Nature reviews. Nephrology (01.08.2017)
Published in Nature reviews. Nephrology (01.08.2017)
Get full text
Journal Article
Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma
Motzer, Robert J., Escudier, Bernard, Gannon, Andrew, Figlin, Robert A.
Published in The oncologist (Dayton, Ohio) (01.01.2017)
Published in The oncologist (Dayton, Ohio) (01.01.2017)
Get full text
Journal Article
Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma
Courtney, Kevin D, Infante, Jeffrey R, Lam, Elaine T, Figlin, Robert A, Rini, Brian I, Brugarolas, James, Zojwalla, Naseem J, Lowe, Ann M, Wang, Keshi, Wallace, Eli M, Josey, John A, Choueiri, Toni K
Published in Journal of clinical oncology (20.03.2018)
Published in Journal of clinical oncology (20.03.2018)
Get full text
Journal Article
S1PR1-STAT3 Signaling Is Crucial for Myeloid Cell Colonization at Future Metastatic Sites
Deng, Jiehui, Liu, Yong, Lee, Heehyoung, Herrmann, Andreas, Zhang, Wang, Zhang, Chunyan, Shen, Shudan, Priceman, Saul J., Kujawski, Maciej, Pal, Sumanta K., Raubitschek, Andrew, Hoon, Dave S.B., Forman, Stephen, Figlin, Robert A., Liu, Jie, Jove, Richard, Yu, Hua
Published in Cancer cell (15.05.2012)
Published in Cancer cell (15.05.2012)
Get full text
Journal Article
Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis
Wu, Xiwei, Weng, Lihong, Li, Xuejun, Guo, Chao, Pal, Sumanta K, Jin, Jennifer M, Li, Yuping, Nelson, Rebecca A, Mu, Bing, Onami, Susan H, Wu, Jeffrey J, Ruel, Nora H, Wilczynski, Sharon P, Gao, Hanlin, Covarrubias, Maricela, Figlin, Robert A, Weiss, Lawrence M, Wu, Huiqing
Published in PloS one (18.05.2012)
Published in PloS one (18.05.2012)
Get full text
Journal Article
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
Motzer, Robert J, Dr, Prof, Escudier, Bernard, MD, Oudard, Stéphane, Prof, Hutson, Thomas E, Prof, Porta, Camillo, MD, Bracarda, Sergio, MD, Grünwald, Viktor, Prof, Thompson, John A, Prof, Figlin, Robert A, Prof, Hollaender, Norbert, PhD, Urbanowitz, Gladys, BS, Berg, William J, MD, Kay, Andrea, MD, Lebwohl, David, MD, Ravaud, Alain, Prof
Published in The Lancet (British edition) (09.08.2008)
Published in The Lancet (British edition) (09.08.2008)
Get full text
Journal Article
Akt inhibitors in clinical development for the treatment of cancer
Pal, Sumanta Kumar, Reckamp, Karen, Yu, Hua, Figlin, Robert A
Published in Expert opinion on investigational drugs (01.11.2010)
Published in Expert opinion on investigational drugs (01.11.2010)
Get more information
Journal Article
Predicting Real-World Effectiveness of Cancer Therapies Using Overall Survival and Progression-Free Survival from Clinical Trials: Empirical Evidence for the ASCO Value Framework
Lakdawalla, Darius N., PhD, Shafrin, Jason, PhD, Hou, Ningqi, PhD, Peneva, Desi, MS, Vine, Seanna, MPH, Park, Jinhee, PhD, Zhang, Jie, PhD, Brookmeyer, Ron, PhD, Figlin, Robert A., MD, FACP
Published in Value in health (01.07.2017)
Published in Value in health (01.07.2017)
Get full text
Journal Article
COVID-19 and androgen-targeted therapy for prostate cancer patients
Bhowmick, Neil A, Oft, Jillian, Dorff, Tanya, Pal, Sumanta, Agarwal, Neeraj, Figlin, Robert A, Posadas, Edwin M, Freedland, Stephen J, Gong, Jun
Published in Endocrine-related cancer (01.09.2020)
Published in Endocrine-related cancer (01.09.2020)
Get full text
Journal Article
Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma: Final Results and Analysis of Prognostic Factors
MOTZER, Robert J, ESCUDIER, Bernard, KAY, Andrea, RAVAUD, Alain, OUDARD, Stephane, HUTSON, Thomas E, PORTA, Camillo, BRACARDA, Sergio, GRÜNWALD, Viktor, THOMPSON, John A, FIGLIN, Robert A, HOLLAENDER, Norbert
Published in Cancer (15.09.2010)
Published in Cancer (15.09.2010)
Get full text
Journal Article
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
MOTZER, Robert J, HUTSON, Thomas E, GARCIA-DEL-MURO, Xavier, SOSMAN, Jeffrey A, SOLSKA, Ewa, WILDING, George, THOMPSON, John A, KIM, Sindy T, CHEN, Isan, XIN HUANG, FIGLIN, Robert A, TOMCZAK, Piotr, MICHAELSON, M. Dror, BUKOWSKI, Ronald M, OUDARD, Stéphane, NEGRIER, Sylvie, SZCZYLIK, Cezary, PILI, Roberto, BJARNASON, Georg A
Published in Journal of clinical oncology (01.08.2009)
Published in Journal of clinical oncology (01.08.2009)
Get full text
Journal Article
HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma
Courtney, Kevin D, Ma, Yuanqing, Diaz de Leon, Alberto, Christie, Alana, Xie, Zhiqun, Woolford, Layton, Singla, Nirmish, Joyce, Allison, Hill, Haley, Madhuranthakam, Ananth J, Yuan, Qing, Xi, Yin, Zhang, Yue, Chang, Jenny, Fatunde, Oluwatomilade, Arriaga, Yull, Frankel, Arthur E, Kalva, Sanjeeva, Zhang, Song, McKenzie, Tiffani, Reig Torras, Oscar, Figlin, Robert A, Rini, Brian I, McKay, Renée M, Kapur, Payal, Wang, Tao, Pedrosa, Ivan, Brugarolas, James
Published in Clinical cancer research (15.02.2020)
Published in Clinical cancer research (15.02.2020)
Get full text
Journal Article
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
Rosenberg, Jonathan E., Bambury, Richard M., Van Allen, Eliezer M., Drabkin, Harry A., Lara, Primo N., Harzstark, Andrea L., Wagle, Nikhil, Figlin, Robert A., Smith, Gregory W., Garraway, Levi A., Choueiri, Toni, Erlandsson, Fredrik, Laber, Damian A.
Published in Investigational new drugs (01.02.2014)
Published in Investigational new drugs (01.02.2014)
Get full text
Journal Article
The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
Rini, Brian I., Battle, Dena, Figlin, Robert A., George, Daniel J., Hammers, Hans, Hutson, Tom, Jonasch, Eric, Joseph, Richard W., McDermott, David F., Motzer, Robert J., Pal, Sumanta K., Pantuck, Allan J., Quinn, David I., Seery, Virginia, Voss, Martin H., Wood, Christopher G., Wood, Laura S., Atkins, Michael B.
Published in Journal for immunotherapy of cancer (20.12.2019)
Published in Journal for immunotherapy of cancer (20.12.2019)
Get full text
Journal Article
Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
Tran, Hai T, PharmD, Liu, Yuan, PhD, Zurita, Amado J, MD, Lin, Ying, PhD, Baker-Neblett, Katherine L, MBA, Martin, Anne-Marie, PhD, Figlin, Robert A, MD, Hutson, Thomas E, DO, Sternberg, Cora N, MD, Amado, Rafael G, MD, Pandite, Lini N, MD, Heymach, John V, Dr
Published in The lancet oncology (01.08.2012)
Published in The lancet oncology (01.08.2012)
Get full text
Journal Article